LieffCabraser – Page 43 – Lieff Cabraser

About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Lieff Cabraser and FeganScott File Lawsuit Alleging NCAA and University of San Francisco Fail to Protect Baseball Players from Sexual Misconduct by Coaches

On March 11, 2022, Lieff Cabraser and FeganScott filed a class-action lawsuit on behalf of three University of San Francisco (USF) Baseball student-athletes against the National Collegiate Athletics Association (NCAA), USF, and two USF coaches, Nino Giarratano and Troy Nakamura, alleging a long-standing history of abuse of student-athletes by the

LieffCabraser2022-03-18T02:54:06+00:00March 11th, 2022|Sexual Abuse|

Treasury Report Reveals that Collusion and Other Illegal Anticompetitive Practices by Employers Suppress Worker Pay and Job Opportunities Across the U.S.

Government’s new report shows that employers face little competition for workers, allowing companies to pay employees substantially less than a so-called “free” market would manifest A new study has been released by the U.S. government revealing that despite a purported “tight” labor market that should give workers leverage, in fact the system is deeply flawed

LieffCabraser2022-03-09T02:29:41+00:00March 9th, 2022|Antitrust, Employment Law|

Jessica Moldovan to be Featured on American Academy of Matrimonial Lawyers Panel “The Threat to Roe, Then and Now” About the Current State of Reproductive Rights

On Wednesday, March 9th, 2022, Lieff Cabraser attorney Jessica Moldovan will speak at the AAML NY Chapter Annual March Program on the topic, “The Threat to Roe, Then and Now.” The CLE-credit program was set up by the Chapter’s Social Action Committee, and also features Slate Magazine’s News Director, Susan Matthews. As the program notes,

LieffCabraser2022-03-07T20:51:33+00:00March 7th, 2022|Firm News|

President Biden Signs “Ending Forced Arbitration of Sexual Assault and Sexual Harassment” Act into Law

On March 3, 2022, President Biden signed into law the Ending Forced Arbitration of Sexual Assault and Sexual Harassment Act of 2021, which restores survivors’ option to hold their abusers accountable in public court rather than in secretive, private arbitration (often funded by the defendant). The law prohibits employers from imposing the provisions of arbitration

LieffCabraser2022-03-04T21:23:40+00:00March 4th, 2022|Employment Law|

WHO Releases Detailed Report on Negative Impacts of Aggressive Formula Milk Marketing on New Parents

The World Health Organization and UNICEF have published a new report that summarizes the findings of a multi-national study examining the impact of formula milk marketing on infant feeding decisions and practices. The research study, the largest of its kind to date, draws on the experiences of over 8,000 women and more than 300 health

LieffCabraser2022-03-03T22:03:00+00:00March 3rd, 2022|Accidents & Safety Recalls, Infant & Child Injuries, Personal Injury|

Abbott Labs Expands Urgent Recall of Similac, Alimentum, EleCare After Second Infant Death

Potentially lethal bacteria feared to be present in Abbott’s powdered milk products aimed at infants Abbott Laboratories has expanded its nationwide emergency recall of three infant powdered milk products after a second infant has died after using the formula. Originally recalled on February 18, 2022, the formula variations were all produced at Abbott’s manufacturing facility

LieffCabraser2022-03-02T16:36:13+00:00March 2nd, 2022|Accidents & Safety Recalls, Infant & Child Injuries, Personal Injury|

Michelle Lamy Named to Bloomberg Law’s “They’ve Got Next: Five Fresh Faces to Know in Consumer Litigation”

We are delighted to announce that Lieff Cabraser partner Michelle Lamy has been named to Bloomberg Law’s “They’ve Got Next: Five Fresh Faces to Know in Consumer Litigation.”

LieffCabraser2022-02-28T18:51:27+00:00February 28th, 2022|Firm News|

Thousands of U.S. communities to receive opioid recovery funds from $26 billion global settlements as soon as May 2022

Over 90% of litigating local governments have confirmed participation in the global settlements approved today by the “Big Three” drug distributors AmerisourceBergen, Cardinal Health, and McKesson, along with opioid manufacturer Johnson & Johnson Washington, D.C. (February 25, 2022) – Today, the National Prescription Opiate Litigation Plaintiffs’ Executive Committee confirmed participation of over 90% of litigating

LieffCabraser2022-02-25T18:04:51+00:00February 25th, 2022|Mass Tort, Prescription Drug Injuries, Public Good|

Anne Shaver Pens Compelling Piece for Impact Fund: Ninth Circuit Finds Discrimination To Be Concrete Injury For Purposes Of Article III Standing

The following is from a piece published by the Impact Fund written by Lieff Cabraser partner Anne B. Shaver, explaining a recent Ninth Circuit decision to reject an attempt to insulate a bank from liability for admitted citizenship discrimination on standing grounds.

LieffCabraser2023-04-19T19:24:44+00:00February 22nd, 2022|Discrimination, Firm News|

Jallé Dafa to Moderate ABA Section of Labor & Employment Law’s Black History Month Roundtable

Lieff Cabraser attorney Jallé Dafa will moderate the first of the ABA Labor & Employment Law Section’s Heritage Month Webinar Series on Thursday, February 24, 2022 at 12:00 pm CST. In recognition of Black History Month, the Section has assembled an extraordinary set of panelists for a roundtable conversation discussing their entries to the legal field, career

LieffCabraser2022-02-23T01:48:01+00:00February 22nd, 2022|Firm News|

Previous 424344 Next